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Abstract: With 200,000 annual deaths in the United States due to pulmonary embolism (PE), 
efficient and accurate diagnosis is mandatory. Since negative D-dimer values are only useful in 
ruling out PE, elevated values alone should not result in excessive testing. This study assessed 
the diagnostic and financial yield of the D-dimer in diagnosing PE. This retrospective review of 
220 medical records of patients at a South Chicago Community Hospital explored the extent of 
the work-up following an elevated D-dimer for a suspected PE. Patients were randomly selected 
with no exclusion criteria. Five of the 118 (4.2%) patients with elevated D-dimer values were 
diagnosed with a PE. Tests ordered based on elevated D-dimer values were billed for more 
than $200,000. The current diagnostic approach has been medically and financially inefficient. 
Patients should not be worked-up for a PE based primarily on an elevated D-dimer value. Two 
prominent factors, independent of PE, that result in elevated D-dimer values and were pertinent 
to the studied population, are age and African-American origin. Implementing a scoring system, 
like the revised-Geneva scale, will establish a better index of suspicion to improve both the 
physician’s diagnostic approach and the yield of the work-up.
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Practice recommendations
This evaluation illustrated that without the implementation of an appropriate scaling 
system, the work-up to rule out PE is of low yield. Consequences of excessive testing 
include unnecessary exposure to radiation and financial wastefulness.
The implementation of clinical prediction rules will improve the diagnostic 
approach, management, and utilization of resources.
The use of a scaling system will also account for the possibility of normal 
  physiologic or pathologic conditions, other than PE, that may attribute to the   elevation 
of D-dimer values.
Introduction
Pulmonary Embolism (PE) is a very dangerous disease state, as it presents with 
nonspecific symptoms that can lead to death within a few hours of onset. As many 
as 200,000 deaths per year in the United States are due to PE, making this the third 
leading cardiovascular cause of death of inpatient groups.1 Any patient who is at risk 
for venous thrombosis must be watched carefully, since 50% to 60% of these patients 
can develop PE.1 There has been a corresponding rise in diagnostic studies being 
conducted based on suspicion of PE.
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The rates of unexpected death due to PE are second 
only to cardiac arrest. Of those patients who develop PE, 
approximately 10% will die within the first hour, while 
another 30% will die from a recurrent case of emboli.2 With 
improved and increased accuracy of diagnosing PE, 25% of 
those who currently die from PE could be saved.2 However, 
the concern of missing the diagnosis of PE should not give 
way to unnecessary orders for tests without adequate basis 
for those orders.
It has been noted in the past that the D-dimer value can be 
systematically elevated in cases of deep venous thrombosis or 
PE. However, the D-dimer value can be elevated in a number 
of other normal physiologic, as well as pathologic states. 
Hence finding the D-dimer level to be elevated should not 
be the sole basis for a PE workup. Rather, clinical suspicion 
should direct the investigation for the presence of PE. With 
the aid of appropriate labs and imaging studies, the diagnosis 
of PE can be made quickly and adequate treatment can be 
initiated in a short period of time. The purpose of this study 
is to demonstrate that an elevated D-dimer value alone often 
results in extensive PE workup, which has a low diagnostic 
and economical yield.
Method
A retrospective analysis of the diagnosis of PE at Jackson 
Park Hospital (JPH) was conducted. JPH is a short-term, 
comprehensive care facility serving the south side of 
Chicago, IL. The hospital serves a very high indigent, adult, 
African-American population. The analysis focused on the 
use of the D-dimer and CT scan of the thorax with contrast. In 
an attempt to minimize bias, there were no exclusion criteria. 
The charts of 220 patients having a D-dimer test ordered 
at the hospital were randomly selected for review. Factors 
evaluated for these patients included levels of the HemosIL 
assay of the D-dimer and subsequent tests ordered, including 
ventilation/perfusion scan (V/Q scan), Doppler studies and 
CT scan of the thorax with contrast.
To assess the consistency in the approach to diagnosing 
a PE, the sequence of events leading to the suspicion and 
ultimate diagnosis was considered in the patients diagnosed 
with a PE. The factors for each of the cases that were 
considered included clinical suspicion, D-dimer, the use of 
arterial blood gases, V/Q scan, Doppler studies, and CT of 
the thorax with contrast. While it was possible to investigate 
these tests, the current lack of a widely accepted and used PE 
protocol at the hospital resulted in limitations to objectively 
identifying the ordering physician’s clinical and laboratory 
rationale behind the tests.
Results
The study consisted of reviewing 220 patients who had one or 
more D-dimer tests ordered. Of the 220 patients, 217 patients 
had D-dimer values. The three patients without values had 
the test done but results were not available. 118 out of the 
217 patients (54.4%) had elevated D-dimer values greater 
than 254 ng/mL. Of these 118 patients, five were diagnosed 
with pulmonary emboli, resulting in a positive predictive 
value of 4.2%.
Ninety-two follow up tests were ordered for the 
118 patients with elevated D-dimer values. Some of these 
patients may have had more than one follow-up test ordered 
while some patients had no further tests ordered. Thirty-four 
of the 92 tests ordered were venous Doppler studies (36.9%), 
36 were CT of the thorax (39.1%) and 22 were V/Q scans 
(23.9%). Out of the 118 patients with elevated D-dimer, five 
were diagnosed with PE.
Cost analysis
When considering the group of patients who had the 
D-dimer test ordered, those having elevated values often had 
subsequent tests ordered, including V/Q scans, CT scans of 
the thorax with contrast and lower venous Doppler studies. 
Summarized in the Table 3 is average cost and reimbursement 
(as per Medicaid) for the tests ordered in the 118 cases of 
elevated D-dimer values.
Discussion
The prevalence of PE and the associated mortality undoubtedly 
warrant sufficient work-up when there is clinical suspicion. 
The current approach to diagnosing PE has been inefficient, 
as there is an overly liberal use of the D-dimer lab test and 
chest CT scan. This exposes the patient to high doses of radia-
tion, increases costs, and delays the disposition of patients.3 
It is evident that the diagnostic approach must be altered to 
efficiently and effectively diagnose pulmonary emboli.
The D-dimer lab test is considered to be highly sensitive, 
but non-specific.4 As a result, the role of this test has typically 
been limited to ruling out a PE in cases of low suspicion.4 
However, there are various formulations of the D-dimer test 
itself, each with different sensitivities. The HemosIL assay, 
used at JPH, has sensitivities comparable to the gold standard 
VIDAS ELISA assay.5 Due to such high sensitivity, when a 
D-dimer assay result is negative, PE can be confidently ruled 
out. Sensitivity, negative predictive value, turnaround time for 
the results and cost all play important roles when selecting 
a particular D-dimer assay. Turnaround time is important 
since a PE needs to be ruled out as quickly as possible. 
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  Cost-effective assays are important in community hospitals 
like JPH. Although the ELISA may be the gold standard assay, 
since the sensitivity, negative predictive value,   turnaround 
time, and cost of the new generation latex agglutination 
D-dimer assays are comparable and in some instances better, 
they are more advantageous than the ELISA.
Heterogeneity is a major problem with D-dimer 
  measurement. There has been great confusion resulting 
from multiple commercial assays having various techniques, 
cut-offs, systems of units, operational characteristics, and 
clinical validity. Since D-dimer is a complex mixture of 
degradation products of different sizes, standardization has 
not been possible.6
While many assays typically use cut-off values of 
500 ng/mL, studies found that the lower cut-off values with 
the HemosIL assay demonstrated not only safe exclusion of 
venous thromboembolism, but also proved specificity and 
exclusion rates similar to other formulations.5 As a result, 
at JPH, the threshold for the D-dimer value is 254 ng/mL. 
However, according to the literature, D-dimer values greater 
than 500 ng/mL are considered positive.7 If the threshold 
for an elevated D-dimer had been increased to 500 ng/mL 
in this study of the 217 patients from the D-dimer group, 66 
would have had an elevated D-dimer, of whom 5 were diag-
nosed with a PE. A distribution of these D-dimer values is 
illustrated in Figure 1. Although a normal D-dimer value is 
used to rule out PE, an elevated D-dimer value alone cannot 
indicate a PE. There are many factors that can contribute to 
the elevation of a D-dimer lab value. D-dimer can be elevated 
in advanced age, pregnancy, trauma, post-operative periods, 
inflammatory states, and cancer4 (Table 1). Also, it has 
been found that the D-dimer values are markedly higher in 
African-Americans, who are four times more likely to have 
an extreme value (.600 ng/mL) than Caucasians.8 This is 
significant because the vast majority of the patient population 
at JPH is of African-American origin.
In a study by Harper et al,9 it has been found that the 
median D-dimer concentration increased with age from 
294 ng/mL in people aged 16–40 years; to 387 ng/mL in those 
aged 40–60 years; to 854 ng/mL in those aged 60–80 years; 
to 1397 ng/mL in those aged 80+ years. The assay specificity 
decreased with age from 70% in patients ,40 years to less 
than 5% in patients .80 years.9 This trend is of particular 
interest because age is a risk factor for PE as well as con-
tributing to an elevated D-dimer. The D-dimer values of the 
220 patients in different age groups, both in the literature8 
and at JPH, is presented in Table 2. While the average value 
is increased in the older groups, it is possible that in a larger 
follow-up analysis, the trend may correlate more with that 
seen in the study conducted by Harper et al.9 Douma et al10 
found that an age-adjusted D-dimer cut-off point, combined 
with clinical probability, generally increased the proportion of 
older patients in whom PE could be safely excluded. Raising 
the cut-off value of the D-dimer test for older patients to 
values between 600 ng/mL and 1000 ng/mL increases the 
test’s specificity, but at the cost of safety. They suggested a 
new D-dimer cut-off value to be (patient’s age × 10) µg/L in 
patients older than fifty years.10
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Figure 1 A distribution of the 66 out of 217 D-dimer values that were above 500 ng/mL. 
Note: The 5 diagnosed pulmonary embolisms are represented numerically in the corresponding D-dimer value.
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Of the five patients diagnosed with a PE, four were older 
than 60 years. The diagnostic value of the D-dimer must thus 
be cautiously considered. More than 95% of the 220 patients 
investigated were African American. Of the patients studied, 
17.1% were between the ages of 16–39 years, 46.1% were 
between the ages of 40–59, 28.6% were between the ages of 
60–79, and 7.8% were over 80 years of age. The literature 
indicates that the positive predictive value of the D-dimer test 
in diagnosing a PE is approximately 20%.11 At JPH the PPV 
of 4.2% was markedly less. This may be due to the elevated 
D-dimer values in the predominantly African American and 
elderly population at the hospital.
The combination of the present clinical judgment and 
rationale by different physicians in the evaluation of PE 
has resulted in very low yields from the tests. The common 
practice has been either over-defensive, neglected to account 
for other possible causes of elevated D-dimer values, or a 
combination of both. This disparity further supports the need 
to consider normal physiologic and pathologic conditions, 
other than PE, that can cause an elevated D-dimer. Moderate 
sensitivity and specificity of clinical signs and symptoms 
of PE prevent the diagnosis from being made solely on a 
clinical basis. The traditional gold standard of pulmonary 
angiography is invasive and resource demanding. Submitting 
all patients suspected of having a PE to imaging would not be 
cost effective. To efficiently and cost-effectively work-up a 
suspected PE, institution-wide clinical prediction rules must 
be implemented.12
Due to the high false positive rate of the D-dimer, there 
has been an increase in the use of radiological imaging, length 
of patient stay, and false positive diagnoses.13 The diagnosis 
of any illness always begins with a thorough patient history 
and physical exam. The first step for the diagnosis of a PE 
should also be the same. The most extensively validated 
guidelines have been the Wells and Geneva scores. These 
initial guidelines require diagnostic tests, such as chest x-ray 
or arterial blood gas analysis on room air, that are not always 
available. More recent rules, like the revised-Geneva scoring 
scale, are based only on clinical elements and it has been 
demonstrated that patients can be safely managed based on 
clinical assessment utilizing these scores. Implementing a 
scoring system (Figure 2) would establish an appropriate 
index of suspicion and improve the diagnostic approach 
towards PE.14 It would also reduce the financial burden of 
over-testing for suspected PE by increasing the yield of the 
work-up.
The most significant change in the diagnostic approach 
to acute and chronic PE during the past years has been 
the utilization of the spiral CT scan. Many clinicians have 
used the spiral CT scan in situations when other diagnostic 
techniques, for example the ventilation/perfusion scan, have 
failed to yield a definite diagnosis. According to a study by 
Ost et al,15 the spiral CT has led to an improvement in the 
diagnosis rate of PE from 1.8 per 1000 hospital admissions 
to 2.8 per 1000 admissions. In addition to this diagnostic 
improvement, the perception of the spiral CT being a non-
invasive technique has made it favourable. Even with the 
diagnostic improvement of the spiral CT, only one third of 
patients suspected of PE actually were diagnosed with a PE 
in the study by Ost et al. The remaining two thirds often had 
such conditions as aortic dissection, pneumonia, lung cancer, 
metastasis and pneumothorax, all of which are conditions 
that could be diagnosed with the aid of the CT scan. Despite 
this advancement, there are numerous inconclusive CT scan 
results.15 These results may be attributed to the fact that 
current techniques for CT arteriography have the greatest 
Table 1 Disorders associated with an increased D-dimer value
Arterial thromboembolic disease
Nephrotic syndrome (eg, renal vein thrombosis)
Normal pregnancy
Severe infection/sepsis/inflammation
Surgery/trauma (eg, tissue ischemia, necrosis)
Intracardiac thrombus
Venous thromboembolic disease
Acute limb ischemia
Pulmonary embolism
Vasoocclusive episode of sickle cell disease
Preeclampsia and eclampsia
Abnormal fibrinolysis; use of thrombolytic agents
Chronic renal failure and underlying cardiovascular disease
Malignancy
Cardiovascular disease, congestive failure
Deep vein thrombosis
Atrial fibrillation
Acute renal failure
Renal disease
Systemic inflammatory response syndrome
Severe liver disease (decreased clearance)
Myocardial infarction
Stroke
Disseminated intravascular coagulation
Table 2 A comparison between the literature and JPH of the 
D-dimer values (ng/mL) for each age group
Age group Literature median  
D-dimer
Mean D-dimer   
in JPH study
16–39 294 490
40–59 387 400
60–79 854 552
80+ 1397 899
Abbreviation: JPH, Jackson Park Hospital (Chicago, IL).
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sensitivity and specificity for detecting emboli in the main 
and lobar arteries.16 The spiral CT scan has a sensitiv-
ity of 57%–100% and specificity of 78%–100%, both of 
which vary with the location of the emboli. Both values are 
approximately 90% in the main and lobar pulmonary   arteries 
however there is a marked decrease in the segmental and 
sub-segmental pulmonary vessels.4 Even though CT scans 
are of great advantage, they expose the patient to substantial 
amounts of radiation which can lead to health risks associ-
ated with radiation exposure. Although CT scans can be 
useful in diagnosis of PE, an increased D-dimer should not 
be the sole reason for a CT scan to be ordered. The average 
annual natural background radiation exposure is 2.5 mSv 
compared to 7.0 mSv of radiation exposure with one CT scan. 
Wells score  Geneva score  Revised Geneva score 
Items Items Items Score Score Score
Previous PE or DVT
Heart rate > 100
Recent surgery or immobilization
Clinical signs of DVT
Alternative diagnosis less likely than PE
Hemoptysis
Cancer
Age > 65 years
Previous DVT or PE
Surgery or fracture within 1 month
Active malignancy
Unilateral lower limb pain
Hemoptysis
Heart rate
75–94
≥95
Pain on lower limb deep vein palpation
and unilateral edema
Previous PE or DVT
Heart rate > 100
Recent surgery
Age
60−79
≥80
Arterial blood gases
CO2 (kPa)
<4.8
<6.5
6.5–7.99
Clinical probabilityC linical probability Clinical probability
8–9.49
9.5–10.99
Chest X-ray
Atelectasis
Elevated hemidiaphragm
4.8–5.19
O2 (kPa)
Low <2
1.5  2 
1 
3 
1 
2 
1 
3 
2 
2 
3 
2 
3 
5 
4 
2 
1 
4 
3 
2 
1 
1 
1 
1.5 
1.5 
3 
3 
1 
1 
2−6
>6
0–4
2−6
≥9 ≥11
0–3
4−10
≤4
>4
Intermediate
High
Low
Intermediate
High
Low
Intermediate
High
Dichotomized 
PE unlikely
PE likely
Figure 2 The Wells, Geneva, and revised-Geneva pre-test possibility scores.6 
Abbreviations: PE, pulmonary embolism; DVT, deep vein thrombosis.
Table 3 A breakdown of the average cost and reimbursement (by Medicaid and Medicare) of the tests commonly ordered while 
considering a pulmonary embolism
Test Number Average 
cost ($)
Total cost  
($)
Average medicaid 
reimbursement ($)
Total medicaid 
reimbursement ($)
Average medicare 
reimbursement ($)
Total medicare 
reimbursement ($)
D-dimer  
(85379)
118 $256.00 $30,280.00 $7.50 $885.00 $21.24 $2,506.32
V/Q scan  
(78588)
22 $2,400.00 $52,800.00 $65.35 $1,437.70 $374.81 $8,245.82
CT thorax 
w/contrast 
(71260)
36 $2,800.00 $100,800.00 $75.90 $2,732.40 $414.97 $14,938.92
Lower  
venous  
Doppler  
(93970)
34 $700.00 $23,800.00 $87.55 $2,976.70 $232.19 $7,894.46
$207,608.00 $8,031.80 $33,585.52
Notes: There were 118 patients (of the 220 total patients with the D-dimer ordered) who had an elevated D-dimer value (.254 ng/mL). In parenthesis, beside the test, is 
the corresponding CPT code. Based on these values, the hospital is typically reimbursed between 4% and 16% of the cost of these tests.
Abbreviations: V/Q scan, ventilation/perfusion scan; CT, computerized tomography.
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This is equivalent to about 140 chest radiographs.17 Patients 
can experience a lifelong impact with the increased risk of 
developing cancer due to the cumulative effects of radia-
tion exposure, whether from a chest radiograph, CT scan or 
environmental. Proper rationale should be exercised before 
ordering a CT scan.
Conclusion
The current approach to diagnosing pulmonary emboli must 
be improved. The current approach has had low yields, 
has been financially wasteful and has caused unnecessary 
radiation exposure to patients. It is imperative that patients 
should not be worked-up for a PE based primarily on an 
elevated D-dimer value, as there are numerous conditions 
and pre-disposing factors, other than a PE, that can cause 
an elevated D-dimer value. Two very prominent factors 
that pertained to the population examined included age and 
African-American origin.
It is proposed that implementing a scoring system, like the 
revised-Geneva scale, will establish a better index of suspi-
cion that will ultimately guide the medical team to improve 
their diagnostic approach, management, and utilization of 
resources. Such a scale will enable patients with a low risk 
for PE to have a D-dimer ordered with the objective of ruling 
out a PE. Using similar scales, patients who are suspected 
to be highly likely to have a PE may have a CT scan of the 
thorax done. Such a system would be systematic and reflect 
sound scientific practice that would be beneficial to the 
patient and hospital, alike.
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